Novonix (NVX) Payables (2020 - 2025)

Novonix (NVX) has 6 years of Payables data on record, last reported at $75.4 million in Q4 2025.

  • For Q4 2025, Payables rose 87.57% year-over-year to $75.4 million; the TTM value through Dec 2025 reached $75.4 million, up 87.57%, while the annual FY2025 figure was $75.4 million, 87.57% up from the prior year.
  • Payables reached $75.4 million in Q4 2025 per NVX's latest filing, up from $40.2 million in the prior quarter.
  • Across five years, Payables topped out at $75.4 million in Q4 2025 and bottomed at $3.6 million in Q2 2021.
  • Average Payables over 5 years is $27.1 million, with a median of $19.8 million recorded in 2022.
  • Peak YoY movement for Payables: increased 6.83% in 2022, then surged 560.69% in 2023.
  • A 5-year view of Payables shows it stood at $3.6 million in 2021, then surged by 45.56% to $5.2 million in 2022, then soared by 560.69% to $34.3 million in 2023, then rose by 17.13% to $40.2 million in 2024, then skyrocketed by 87.57% to $75.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $75.4 million in Q4 2025, $40.2 million in Q4 2024, and $34.3 million in Q4 2023.